These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22816019)

  • 21. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
    Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).
    Sinclair SR; Kane SA; Van der Schueren BJ; Xiao A; Willson KJ; Boyle J; de Lepeleire I; Xu Y; Hickey L; Denney WS; Li CC; Palcza J; Vanmolkot FH; Depré M; Van Hecken A; Murphy MG; Ho TW; de Hoon JN
    Br J Clin Pharmacol; 2010 Jan; 69(1):15-22. PubMed ID: 20078608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.
    Paone DV; Staas DD
    Expert Opin Ther Pat; 2009 Dec; 19(12):1675-713. PubMed ID: 19939188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
    Villalón CM; Olesen J
    Pharmacol Ther; 2009 Dec; 124(3):309-23. PubMed ID: 19796656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of acute and chronic migraine.
    Coppola G; Schoenen J
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):177-82. PubMed ID: 22406987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimigraine efficacy of telcagepant based on patient's historical triptan response.
    Ho TW; Olesen J; Dodick DW; Kost J; Lines C; Ferrari MD
    Headache; 2011 Jan; 51(1):64-72. PubMed ID: 21054362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, controlled trial of telcagepant for the acute treatment of migraine.
    Nardin R
    Neurology; 2010 Mar; 74(12):1007; author reply 1007-8. PubMed ID: 20308688
    [No Abstract]   [Full Text] [Related]  

  • 28. Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
    Dodick DW; Kost J; Assaid C; Lines C; Ho TW
    Cephalalgia; 2011 Feb; 31(3):296-300. PubMed ID: 20937606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
    Link AS; Kuris A; Edvinsson L
    J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CGRP antagonists: unravelling the role of CGRP in migraine.
    Doods H; Arndt K; Rudolf K; Just S
    Trends Pharmacol Sci; 2007 Nov; 28(11):580-7. PubMed ID: 17963849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin gene-related peptide receptor antagonists for migraine.
    Fischer MJ
    Expert Opin Investig Drugs; 2010 Jul; 19(7):815-23. PubMed ID: 20482328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcitonin gene-related peptide receptor antagonists for the treatment of migraine.
    Williams TM; Burgey CS; Salvatore CA
    Prog Med Chem; 2009; 47():1-35. PubMed ID: 19328288
    [No Abstract]   [Full Text] [Related]  

  • 33. An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: sign of a possible new chapter in headache medicine.
    Garza I
    Curr Neurol Neurosci Rep; 2009 Mar; 9(2):91-3. PubMed ID: 19268029
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized, controlled trial of telcagepant over four migraine attacks.
    Ho AP; Dahlöf CG; Silberstein SD; Saper JR; Ashina M; Kost JT; Froman S; Leibensperger H; Lines CR; Ho TW
    Cephalalgia; 2010 Dec; 30(12):1443-57. PubMed ID: 20974601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine.
    Depré M; Macleod C; Palcza J; Behm M; de Lepeleire I; Han T; Panebianco D; Smith W; Blanchard R; Chodakewitz J; Murphy M; de Hoon J
    Cephalalgia; 2013 Dec; 33(16):1292-301. PubMed ID: 23798725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CGRP antagonists: novel concept for treatment of migraine].
    Nieber K
    Med Monatsschr Pharm; 2009 May; 32(5):182-5. PubMed ID: 19469188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CGRP receptors in the control of pain and inflammation.
    Benemei S; Nicoletti P; Capone JG; Geppetti P
    Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, controlled trial of telcagepant for the acute treatment of migraine.
    Connor KM; Shapiro RE; Diener HC; Lucas S; Kost J; Fan X; Fei K; Assaid C; Lines C; Ho TW
    Neurology; 2009 Sep; 73(12):970-7. PubMed ID: 19770473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
    Ho TW; Connor KM; Zhang Y; Pearlman E; Koppenhaver J; Fan X; Lines C; Edvinsson L; Goadsby PJ; Michelson D
    Neurology; 2014 Sep; 83(11):958-66. PubMed ID: 25107879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Migraine can signal a risk for heart and brain].
    Vetter C
    MMW Fortschr Med; 2009 Sep; 151(37):17. PubMed ID: 19827419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.